发明名称 Kinase modulation, and indications therefor
摘要 The present disclosure provides methods of using protein kinase inhibitors for treating diseases and conditions, including diseases and conditions associated with activity of any protein kinase selected from Fms protein kinase including any mutations thereof, Kit protein kinase any mutations thereof, Flt-3 protein kinase any mutations thereof and combinations thereof.
申请公布号 US9358235(B2) 申请公布日期 2016.06.07
申请号 US201313802106 申请日期 2013.03.13
申请人 Plexxikon Inc. 发明人 Bollag Gideon;Hirth Klaus-Peter;Ibrahim Prabha N.;Lin Paul;West Brian
分类号 A01N43/42;A61K31/44;A01N43/54;A61K31/505;A61K31/5377;A61K45/06;A61K31/436;A61K31/437;A61K31/4545;A61K31/506;A61K31/444;C07D471/04 主分类号 A01N43/42
代理机构 Sheppard Mullin Richter & Hampton LLP 代理人 Sheppard Mullin Richter & Hampton LLP
主权项 1. A method for treating a subject suffering from pigmented villonodular synovitis (PVNS) or tenosynovial giant cell tumor (TGCT), said method comprising administering to the subject an effective amount of a compound having the formula: or a pharmaceutically acceptable salt, a prodrug, tautomer or an isomer thereof.
地址 Berkeley CA US